BioAZ
PrivateLast Round
Seed
Jan 6, 2026
Total Funding Raised
$1M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
BioAZ operates in Healthcare & Life Sciences and is based in France. Its latest recorded funding round was a Seed round in January 2026.
BioAZ is a biotechnology company that develops innovative immunotherapies for animal health and welfare, focusing on sustainable and ethical solutions for livestock and companion animals.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
BioAZ Comparables
Compare BioAZ with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Zoetis Inc. | 72% | |
| Epivara Inc. | 72% | |
| Ceva Santé Animale | 64% |
For institutional investors. Book with your work email.
BioAZ Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
BioAZ Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Cercle des Vétérinaires Investisseurs | Seed |
| Veterinary Angel Network for Entrepreneurs | Seed |
| Animal Health Angels | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 1, 2026
Monthly visitors increased 1256% MoM.
- Jan 6, 2026
$1M round from multiple angel investors.
For institutional investors. Book with your work email.
BioAZ Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about BioAZ's valuation, stock price, and market status.
Is BioAZ a public or private company?
BioAZ is a private company.
What is the current stock price of BioAZ?
BioAZ is a private company, so its shares have no public market price. Caplight tracks BioAZ's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is BioAZ worth (valuation)?
Valuation information for BioAZ is not publicly available.
Can I buy BioAZ stock?
BioAZ shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was BioAZ's last funding round?
BioAZ's most recent funding round was Seed on January 6, 2026.
Who are the main investors in BioAZ?
Key investors in BioAZ include Cercle des Vétérinaires Investisseurs, Veterinary Angel Network for Entrepreneurs, Animal Health Angels.
Will BioAZ IPO soon?
No public IPO plans have been announced for BioAZ.
How can I track BioAZ secondary market activity?
Caplight tracks bids, offers, and trades in BioAZ's shares on secondary markets.